Antibiotics for the treatment of Cholera, Shigella and Cryptosporidium in children

BMC Public Health

Volumn 13, Issue SUPPL.3, 2013, Pages

  Das, Jai K ^a   Ali, Anum ^a   Salam, Rehana A ^a   Bhutta, Zulfiqar A ^a,b  

^a AGA KHAN UNIVERSITY   (Pakistan)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANIMAL; CHILD; CHILD WELFARE; CHOLERA; CRYPTOSPORIDIOSIS; DEVELOPED COUNTRY; DEVELOPING COUNTRY; DIARRHEA; DYSENTERY, BACILLARY; HUMAN; INFANT; MORTALITY; PRESCHOOL CHILD; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

ANIMALS; ANTI-BACTERIAL AGENTS; CHILD; CHILD WELFARE; CHILD, PRESCHOOL; CHOLERA; CRYPTOSPORIDIOSIS; DEVELOPED COUNTRIES; DEVELOPING COUNTRIES; DIARRHEA; DYSENTERY, BACILLARY; HUMANS; INFANT; RISK FACTORS;

EID: 84884375790     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/1471-2458-13-S3-S10     Document Type: Review

References (37)

1. Levels & Trends in Child Mortality, Estimates Developed by the UN Inter-agency Group for Child Mortality Estimation. UNICEF, New York, NY: UNICEF 2012
2. Cholera in young children in an endemic area. Bhattacharya SK, Datta D, Bhattacharya MK, Garg S, Ramamurthy T, Manna B, Nair GB, Nag A, Moitra A, Lancet 1992 340 8834-8835 1549 1361637
3. The high burden of cholera in children: comparison of incidence from endemic areas in Asia and Africa. Deen JL, von Seidlein L, Sur D, Agtini M, Lucas ME, Lopez AL, Kim DR, Ali M, Clemens JD, PLoS Negl Trop Dis 2008 2 2 173 10.1371/journal.pntd.0000173 18299707 (Pubitemid 352002954)
4. Endemic cholera in rural Bangladesh, 1966-1980. Glass RI, Becker S, Huq MI, Stoll BJ, Khan MU, Merson MH, Lee JV, Black RE, Am J Epidemiol 1982 116 6 959 970 7148820 (Pubitemid 13209569)
5. A 4-year study of the epidemiology of Vibrio cholerae in four rural areas of Bangladesh. Sack RB, Siddique AK, Longini IM Jr., Nizam A, Yunus M, Islam MS, Morris JG Jr., Ali A, Huq A, Nair GB, et al. J Infect Dis 2003 187 1 96 101 10.1086/345865 12508151 (Pubitemid 36034476)
6. Cholera, 2010. World Health Organization, Weekly Epidemiological Record 2010 86 31 325 339
7. Cholera outbreak: assessing the outbreak response and improving preparedness. World Health Organization, WHO: Geneva, Global Task Force on Cholera Control 2004 Available at http://whqlibdoc.who.int/hq/2004/WHO-CDS-CPE- ZFk-2004.4-eng.pdf
8. Guidelines for Operating Makeshift Treatment Centres in Cholera Epidemics. Siddique AK, Nasim SMA, ICDDR, B, Dhaka 1997 Available at https://centre.icddrb.org/images/epidemics.pdf
9. Antibiotics for both moderate and severe cholera. Nelson EJ, Nelson DS, Salam MA, Sack DA, N Engl J Med 364 1 5 7 21142691
10. Guidelines for the control of shigellosis, including epidemics due to Shigella dysenteriae type 1. World Health Organization, WHO Document Production Services, Geneva, Switzerland 2005 Available at http://whqlibdoc.who.int/ publications/2005/9241592330.pdf
11. Important bacterial gastrointestinal pathogens in children: a pathogenesis perspective. Amieva MR, Pediatr Clin North Am 2005 52 3 749 777 vi 10.1016/j.pcl.2005.03.002 15925661 (Pubitemid 40733593)
12. Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005. Ram PK, Crump JA, Gupta SK, Miller MA, Mintz ED, Epidemiol Infect 2008 136 5 577 603 17686195 (Pubitemid 351472169)
13. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM, Bull World Health Organ 1999 77 8 651 666 10516787 (Pubitemid 29446617)
14. Decreasing Shigellosis-related Deaths without Shigella spp.-specific Interventions, Asia. Bardhan P, Faruque ASG, Naheed A, Sack DA, Emerging Infectious Diseases 2010 16 11 1718 10.3201/eid1611.090934 21029529
15. New insights into human cryptosporidiosis. Clark DP, Clin Microbiol Rev 1999 12 4 554 563 10515902 (Pubitemid 29484746)
16. Cryptosporidiosis. A global challenge. Mosier DA, Oberst RD, Ann N Y Acad Sci 2000 916 102 111 11193609
17. Effects of stunting, diarrhoeal disease, and parasitic infection during infancy on cognition in late childhood: a follow-up study. Berkman DS, Lescano AG, Gilman RH, Lopez SL, Black MM, Lancet 2002 359 9306 564 571 10.1016/S0140-6736(02)07744-9 11867110 (Pubitemid 34178438)
18. Management of children with infection-associated persistent diarrhea. Ochoa TJ, Salazar-Lindo E, Cleary TG, Semin Pediatr Infect Dis 2004 15 4 229 236 10.1053/j.spid.2004.07.003 15494946 (Pubitemid 39371103)
19. New drugs and treatment for cryptosporidiosis. Smith HV, Corcoran GD, Curr Opin Infect Dis 2004 17 6 557 564 10.1097/00001432-200412000-00008 15640710 (Pubitemid 39627517)
20. Antibiotic therapy for Shigella dysentery. Christopher PRH, David KV, John SM, Sankarapandian V, The Cochrane Library 2009 19821387
21. Antibiotics for the treatment of dysentery in children. Traa BS, Walker CL, Munos M, Black RE, Int J Epidemiol 2010 39 Suppl 1 70 74 20348130
22. Standards for CHERG reviews of intervention effects on child survival. Walker N, Fischer-Walker C, Bryce J, Bahl R, Cousens S, International journal of epidemiology 2010 39 suppl 1 21 i31 20348122
23. Erythromycin and trimethoprim-sulphamethoxazole in the treatment of cholera in children. Kabir I, Khan WA, Haider R, Mitra AK, Alam AN, J Diarrhoeal Dis Res 1996 14 4 243 247 9203786 (Pubitemid 27272614)
24. A randomized clinical trial to compare the efficacy of erythromycin, ampicillin and tetracycline for the treatment of cholera in children. Roy SK, Islam A, Ali R, Islam KE, Khan RA, Ara SH, Saifuddin NM, Fuchs GJ, Trans R Soc Trop Med Hyg 1998 92 4 460 462 10.1016/S0035-9203(98)91094-X 9850410 (Pubitemid 28409905)
25. Multicenter, randomized, double blind clinical trial of short course versus standard course oral ciprofloxacin for Shigella dysenteriae type 1 dysentery in children. Zimbabwe, Bangladesh, South Africa (Zimbasa) Dysentery Study Group, Pediatr Infect Dis J 2002 21 12 1136 1141 12488664
26. Comparison of pivmecillinam and nalidixic acid in the treatment of acute shigellosis in children. Alam AN, Islam MR, Hossain MS, Mahalanabis D, Hye HK, Scand J Gastroenterol 1994 29 4 313 317 10.3109/00365529409094842 8047805 (Pubitemid 24128378)
27. Randomised comparison of ciprofloxacin suspension and pivmecillinam for childhood shigellosis. Salam MA, Dhar U, Khan WA, Bennish ML, Lancet 1998 352 9127 522 527 10.1016/S0140-6736(97)11457-X 9716056 (Pubitemid 28372225)
28. Comparative efficacy of ceftriaxone and ampicillin for treatment of severe shigellosis in children. Varsano I, Eidlitz-Marcus T, Nussinovitch M, Elian I, J Pediatr 1991 118 4 Pt 1 627 632 2007941
29. Comparative efficacy of nalidixic acid and ampicillin for severe shigellosis. Haltalin KC, Nelson JD, Kusmiesz HT, Arch Dis Child 1973 48 4 305 312 10.1136/adc.48.4.305 4574641
30. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial. Amadi B, Mwiya M, Musuku J, Watuka A, Sianongo S, Ayoub A, Kelly P, Lancet 2002 360 9343 1375 1380 10.1016/S0140-6736(02)11401-2 12423984 (Pubitemid 35341302)
31. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide. Rossignol JF, Ayoub A, Ayers MS, J Infect Dis 2001 184 1 103 106 10.1086/321008 11398117 (Pubitemid 32568508)
32. Spiramycin is not effective in treating cryptosporidium diarrhea in infants: results of a double-blind randomized trial. Wittenberg DF, Miller NM, van den Ende J, J Infect Dis 1989 159 1 131 132 10.1093/infdis/159.1.131 2642518 (Pubitemid 19022009)
33. Cholera. Sack DA, Sack RB, Nair GB, Siddique AK, Lancet 2004 363 9404 223 233 10.1016/S0140-6736(03)15328-7 14738797 (Pubitemid 38114723)
34. Single-dose azithromycin for the treatment of cholera in adults. Saha D, Karim MM, Khan WA, Ahmed S, Salam MA, Bennish ML, New England Journal of Medicine 2006 354 23 2452 2462 10.1056/NEJMoa054493 16760445 (Pubitemid 43855048)
35. Antibiotics for both moderate and severe cholera. Nelson EJ, Nelson DS, Salam MA, Sack DA, New England Journal of Medicine 2011 364 1 5 7 10.1056/NEJMp1013771 21142691
36. Cryptosporidiosis in developing countries. Snelling WJ, Xiao L, Ortega-Pierres G, Lowery CJ, Moore JE, Rao JR, Smyth S, Millar BC, Rooney PJ, Matsuda M, et al. J Infect Dev Ctries 2007 1 3 242 256 19734601
37. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Hunter PR, Nichols G, Clin Microbiol Rev 2002 15 1 145 154 10.1128/CMR.15.1.145-154.2002 11781272 (Pubitemid 34052587)